| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/2005 | CN1217936C Heterocyclic compounds having sulfonamide |
| 09/07/2005 | CN1217932C Antibacterial agents |
| 09/07/2005 | CN1217929C Amycomycin, production thereof and its use as pharmaceutical |
| 09/07/2005 | CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 09/07/2005 | CN1217926C Novel vitamin D analogues |
| 09/07/2005 | CN1217922C 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/07/2005 | CN1217920C Compounds to treat Alzheimer disease |
| 09/07/2005 | CN1217918C Aminocyclohexyl ether compounds and uses thereof |
| 09/07/2005 | CN1217711C Dry powder dispersing apparatus |
| 09/07/2005 | CN1217699C Preventives or remedies for arrhythmia |
| 09/07/2005 | CN1217698C Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 09/07/2005 | CN1217689C Houpo Huanglian Ye (magnolia coptis liguor) for treating piles |
| 09/07/2005 | CN1217683C Prescription of lotion for treating pile and fistula and its preparing process |
| 09/07/2005 | CN1217681C Externally applied paste for treating fracture and injured tendons and its preparing method |
| 09/07/2005 | CN1217679C Traditional Chinese medicinal powder pasted on shenchueh acupoint for treating astriction |
| 09/07/2005 | CN1217677C Medicine for treating rheumatic heart disease |
| 09/07/2005 | CN1217670C Lubricating fluid for sexual intercourse |
| 09/07/2005 | CN1217669C Naringin used in preparing medicine for curing acute and chronic bronchitis |
| 09/07/2005 | CN1217668C Sustained release formulations of erythromycin derivatives |
| 09/07/2005 | CN1217667C Food item capable of increasing cognitive capacity |
| 09/07/2005 | CN1217666C Interleukin-6 production inhibitors |
| 09/07/2005 | CN1217665C Measalazine controlled redease oral pharmaceutical compositions |
| 09/07/2005 | CN1217664C Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength |
| 09/07/2005 | CN1217663C Use of ligustrazine in preparing medicine for treating penis erection dysfunction |
| 09/07/2005 | CN1217662C Cancer treating medicine |
| 09/07/2005 | CN1217661C Choline antagonist sticking preparation |
| 09/07/2005 | CN1217660C IL-8 receptor antagonists |
| 09/07/2005 | CN1217659C Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 09/07/2005 | CN1217658C Organic bio-iodine and its use |
| 09/07/2005 | CN1217657C Method of improving survival of patients |
| 09/07/2005 | CN1217656C Method and pharmaceutical composition for regulating lipid concentration |
| 09/07/2005 | CN1217655C Fibrauretine slow releasing preparation |
| 09/07/2005 | CN1217654C Metered dose inhaler for albuterol |
| 09/07/2005 | CN1217652C Cosmetic method of treating skin |
| 09/07/2005 | CN1217651C Skin care compositions containing cis-9, trans-11 linoleic acid |
| 09/07/2005 | CN1217577C Active substance combinations with insecticidal and acaricidal properties |
| 09/06/2005 | US6939992 Polymorphic forms of sertraline hydrochloride |
| 09/06/2005 | US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/06/2005 | US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/06/2005 | US6939988 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them |
| 09/06/2005 | US6939973 building block is a substituted amine radical |
| 09/06/2005 | US6939971 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent |
| 09/06/2005 | US6939965 Process of manufacture of 1,3-oxathiolane nucleosides using titanium trichloride mono-isopropoxide |
| 09/06/2005 | US6939937 Mold inhibitor integrated within a matrix and method of making same |
| 09/06/2005 | US6939897 Method and composition for inhibiting arteriosclerosis |
| 09/06/2005 | US6939896 Naphthalenedione derivatives; treating autoimmune diseases and organ graft rejection |
| 09/06/2005 | US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine, |
| 09/06/2005 | US6939894 Methods for reducing excessive barking of a dog |
| 09/06/2005 | US6939893 side effect reduction of anticarcinogenic agents, by administering irinotecan and/or taxol, with group VI compounds such as seleno-L-methionine |
| 09/06/2005 | US6939892 Compositions for treating or preventing malaria and method of treating malaria |
| 09/06/2005 | US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/06/2005 | US6939889 Quarternary ammonium compounds |
| 09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 09/06/2005 | US6939884 Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof |
| 09/06/2005 | US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/06/2005 | US6939881 Methods for prevention of ulcers and improving physiological performance |
| 09/06/2005 | US6939880 Compounds with growth hormone releasing properties |
| 09/06/2005 | US6939879 Serotinin receptor antagonist |
| 09/06/2005 | US6939876 Mixture of analgesic and addition reducting compound of a gamma-aminobutyric acid |
| 09/06/2005 | US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders |
| 09/06/2005 | US6939874 Substituted pyrimidinyl derivatives and methods of use |
| 09/06/2005 | US6939873 Non-sedating barbituric acid derivatives |
| 09/06/2005 | US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 09/06/2005 | US6939871 Central nervous system disorders including depression and/or anxiety; 5-HT1 type receptor and/or serotonin reuptake inhibition activity |
| 09/06/2005 | US6939868 Anticancer agents; skin disorders; bone disorders |
| 09/06/2005 | US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
| 09/06/2005 | US6939866 Antitumor agents; skin disorders; anticancer agents |
| 09/06/2005 | US6939865 Cardiovascular disorders; antiarrhythmia agents |
| 09/06/2005 | US6939864 Animal feed compositions and methods of using the same |
| 09/06/2005 | US6939863 Drug coated stent |
| 09/06/2005 | US6939862 Method for transferring nucleic acid into striated muscles |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939859 Skin preparations for external use |
| 09/06/2005 | US6939858 For therapy and prophylaxis of hyperglycemia |
| 09/06/2005 | US6939856 For use as extended release antihistamines |
| 09/06/2005 | US6939855 Anti-inflammatory compositions and method |
| 09/06/2005 | US6939853 Administering glucagon-like peptide 1 (GLP-1) compound and an effective amount of an antidyslipidemic drug for therapy of dyslipidemia |
| 09/06/2005 | US6939840 Disinfectant |
| 09/06/2005 | US6939715 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 09/06/2005 | US6939668 Pre-treatment of lung transplants to reduce susceptibility to post-operative B. cepacia infection are provided. The methods and compositions employ saccharides, particularly dextrans and xylitol, which are applied to the lung transplant before |
| 09/06/2005 | US6939570 Composition and methods for treating Alzheimer's disease and other amyloidoses |
| 09/06/2005 | US6939565 Protease inhibitors of the coagulation cascade isolated from Dysidea sponges |
| 09/06/2005 | US6939564 core of the supramolecular assembly, whereas the shell consists of uncharged hydrophilic polymers; inclusion of the hydrophobic co-monomers to the polyelectrolyte segment forming the micelle core leads to a structure of enhanced stability |
| 09/06/2005 | US6939563 Use of a polyol selected from polyoxyethylene glycol or ethylene glycol-propylene glycol copolymer, a non-fermented osmotic laxative as an anticarcinogenic agent for treating colon or rectum cancer |
| 09/06/2005 | US6939561 Methods and compositions for polyene antibiotics with reduced toxicity |
| 09/06/2005 | US6939560 Pharmaceutical composition having two coating layers |
| 09/06/2005 | US6939559 Pharmaceutical composition for application to mucosa |
| 09/06/2005 | US6939550 Storage stability |
| 09/06/2005 | US6939542 Contacting vitreous humor with beta-glucuronidase, matrix metalloproteinase, chondroitinase, chondroitin sulfatase, and/or protein kinase; thimerosal-free |
| 09/06/2005 | US6939541 Polypeptide for use in the treatment of viral diseases and cancer |
| 09/06/2005 | US6939539 present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons |
| 09/06/2005 | US6939538 Extended release analgesic for pain control |
| 09/06/2005 | US6939376 Drug-delivery endovascular stent and method for treating restenosis |
| 09/06/2005 | US6938832 Scent strip |
| 09/06/2005 | CA2278025C Aqueous suspension for nasal administration |
| 09/06/2005 | CA2275592C Method for preparing a tetrahydropyridin derivative |
| 09/06/2005 | CA2250395C Eprosartan dihydrate and a process for its production and formulation |
| 09/06/2005 | CA2243981C Food and vitamin preparations containing the natural isomer of reduced folates |
| 09/06/2005 | CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them |
| 09/06/2005 | CA2193329C Water soluble rapamycin esters |